BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth August 30, 2022
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence August 24, 2022
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022 August 17, 2022
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute July 21, 2022
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center July 7, 2022
